{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:22:10Z","timestamp":1789464130283,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["278709"],"award-info":[{"award-number":["278709"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2302-z","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T05:55:11Z","timestamp":1511934911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke"],"prefix":"10.1186","volume":"18","author":[{"name":"for the EuroHYP-1 trial investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Winkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Bath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-8129","authenticated-orcid":false,"given":"Jane","family":"Lindschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bart","family":"van der Worp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R.","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Durand-Zaleski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,29]]},"reference":[{"issue":"5","key":"2302_CR1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/ijs.12294","volume":"9","author":"HB Worp van der","year":"2014","unstructured":"van der Worp HB, Macleod MR, Bath PM, Demotes J, Durand-Zaleski I, Gebhardt B, Gluud C, Kollmar R, Krieger DW, Lees KR, Molina C, Montaner J, Roine RO, Petersson J, Staykov D, Szabo I, Wardlaw JM, Schwab S. EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke. 2014;9(5):642\u20135.","journal-title":"Int J Stroke"},{"issue":"7365","key":"2302_CR2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.325.7365.652","volume":"325","author":"D Fergusson","year":"2002","unstructured":"Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ. 2002;325(7365):652\u20134.","journal-title":"BMJ"},{"key":"2302_CR3","unstructured":"Allison DB. Handling missing data by maximum likelihood. SAS Global Forum; 2012. \nhttp:\/\/www.statisticalhorizons.com\/wp-content\/uploads\/MissingDataByML.pdf\n\n. Accessed 13 Nov 2017."},{"key":"2302_CR4","doi-asserted-by":"crossref","DOI":"10.1002\/9781119942283","volume-title":"Multiple imputation and its application. Statistics in practice","author":"JR Carpenter","year":"2013","unstructured":"Carpenter JR, Kenward MG. Multiple imputation and its application. Statistics in practice. Chichester: Wiley; 2013."},{"issue":"24","key":"2302_CR5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581\u20137.","journal-title":"N Engl J Med"},{"issue":"12","key":"2302_CR6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S1474-4422(14)70258-3","volume":"13","author":"CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration","year":"2014","unstructured":"CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial. Lancet Neurol. 2014;13(12):1186\u201392.","journal-title":"Lancet Neurol"},{"issue":"4","key":"2302_CR7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/STROKEAHA.111.680298","volume":"44","author":"M Dennis","year":"2013","unstructured":"Dennis M, Sandercock P, Reid J, Graham C, Murray G, Venables G, Rudd A, Bowler G. The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2. Stroke. 2013;44(4):1075\u20139.","journal-title":"Stroke"},{"issue":"3-4","key":"2302_CR8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000443801","volume":"4","author":"S Rangaraju","year":"2016","unstructured":"Rangaraju S, Frankel M, Jovin TG. Prognostic value of the 24-hour neurological examination in anterior circulation ischemic stroke: a post hoc analysis of two randomized controlled stroke trials. Interv Neurol. 2016;4(3-4):120\u20139.","journal-title":"Interv Neurol"},{"issue":"8","key":"2302_CR9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1474-4422(13)70130-3","volume":"12","author":"The IST-3 collaborative group","year":"2013","unstructured":"The IST-3 collaborative group. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol. 2013;12(8):768\u201376.","journal-title":"Lancet Neurol"},{"key":"2302_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2014.10.010","volume":"7","author":"M Krongold","year":"2014","unstructured":"Krongold M, Almekhlafi MA, Demchuk AM, Coutts SB, Frayne R, Eilaghi A. Final infarct volume estimation on 1-week follow-up MR imaging is feasible and is dependent on recanalization status. Neuroimage Clin. 2014;7:1\u20136.","journal-title":"Neuroimage Clin."},{"issue":"10","key":"2302_CR11","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1161\/STROKEAHA.110.592295","volume":"41","author":"TM Hemmen","year":"2010","unstructured":"Hemmen TM, Raman R, Guluma KZ, Meyer BC, Gomes JA, Cruz-Flores S, Wijman CA, Rapp KS, Grotta JC, Lyden PD. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke. 2010;41(10):2265\u201370.","journal-title":"Stroke"},{"key":"2302_CR12","first-page":"52","volume-title":"Multiple testing problems in pharmaceutical statistics","author":"A Dmitrienko","year":"2010","unstructured":"Dmitrienko A, Tamhane AC, Bretz F. Multiple testing problems in pharmaceutical statistics. Boca Raton: CRC Biostatistics Series: Chapman and Hall; 2010. p. 52\u201370."},{"issue":"2","key":"2302_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","volume":"16","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2):231\u201350.","journal-title":"Value Health"},{"issue":"3","key":"2302_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1099-1050(200004)9:3<191::AID-HEC510>3.0.CO;2-1","volume":"9","author":"M Raikou","year":"2000","unstructured":"Raikou M, Briggs A, Gray A, McGuire A. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. Health Econ. 2000;9(3):191\u20138.","journal-title":"Health Econ"},{"issue":"4","key":"2302_CR15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/sim.4431","volume":"31","author":"BC Kahan","year":"2012","unstructured":"Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med. 2012;31(4):328\u201340.","journal-title":"Stat Med"},{"key":"2302_CR16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1745-6215-9-66","volume":"9","author":"K Dwan","year":"2008","unstructured":"Dwan K, Gamble C, Williamson PR, Altman DG. Reporting of clinical trials: a review of research funders' guidelines. Trials. 2008;9:66.","journal-title":"Trials."},{"issue":"1","key":"2302_CR17","first-page":"5","volume":"11","author":"S Finfer","year":"2009","unstructured":"Finfer S, Bellomo R. Why publish statistical analysis plans? Crit Care Resusc. 2009;11(1):5\u20138.","journal-title":"Crit Care. Resusc."},{"key":"2302_CR18","doi-asserted-by":"crossref","unstructured":"Winkel P, Jakobsen JC, Hilden J, Lange T, Jensen G, Kj\u00f8ller E, Sajadiah A, Kastrup J, Kolmos HJ, Larsson A, Arnlov A, Gluud C. Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): Statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial. Diagn Prognost Res. 2017;1:1\u201310.","DOI":"10.1186\/s41512-017-0009-y"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2302-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T05:55:32Z","timestamp":1511934932000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2302-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,29]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2302-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,29]]},"article-number":"573"}}